Closed
Exercise
Calculated transaction value
$0

Patel Sanj K Chairman & CEO

Transaction date Nov 3, 2026
Public filing date Nov 3, 2026
Filing lag Filed same day

KNSA daily price context

Close on/before transaction
$93.29 Nov 3, 2026
First close after public filing
-- Unavailable
30-day return after filing
-- Through Unavailable

Source details

Reported owner
Not disclosed
Source asset code
Derivative
Security
Share Option on Class A Ordinary Share
Quantity / price
41,237 shares @ $0
SEC ownership
Direct
Transaction code
M
Form
4
Filing identifier
0001532218-26-000018
Filing cohort

Transactions in this filing

Showing 15 of 23
Trades
23
Issuers
1
Estimated value
$39.82M
Buys / sales
0 / 15
Transactions reported in the same official filing
Issuer Transaction Traded Value
Kiniksa Pharmaceuticals International, Plc KNSA Current Exercise Nov 3, 2026 $0
Kiniksa Pharmaceuticals International, Plc KNSA Sale Nov 3, 2026 $13.63M
Kiniksa Pharmaceuticals International, Plc KNSA Sale Nov 3, 2026 $432.04K
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Nov 3, 2026 $786.66K
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Nov 3, 2026 $738.97K
Kiniksa Pharmaceuticals International, Plc KNSA Sale Nov 3, 2026 $110.19K
Kiniksa Pharmaceuticals International, Plc KNSA Sale Nov 3, 2026 $6.37M
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Nov 3, 2026 $0
Kiniksa Pharmaceuticals International, Plc KNSA Sale Nov 2, 2026 $2.22M
Kiniksa Pharmaceuticals International, Plc KNSA Sale Nov 2, 2026 $9.4K
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Nov 2, 2026 $0
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Nov 2, 2026 $471.35K
Kiniksa Pharmaceuticals International, Plc KNSA Sale Nov 2, 2026 $3.49M
Kiniksa Pharmaceuticals International, Plc KNSA Sale Nov 2, 2026 $2.49M
Kiniksa Pharmaceuticals International, Plc KNSA Sale Oct 30, 2026 $3.79M